
About Lexogen
Lexogen is a Healthcare company based in Vienna (Austria) founded in 2007. Complete transcriptome analysis is enabled by kits and software. Its website lexogen.com draws about 17 thousand monthly visits. Lexogen offers products and services including QuantSeq 3β mRNA-Seq Library Prep Kits, RiboCop rRNA Depletion Kits, and SLAMseq Metabolic RNA Labeling Kit. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis. Its legal entity is Lexogen GmbH.
Company details
Lexogen was founded in 2007 in Vienna, Austria, within the biotechnology sector focused on RNA research. Expression profiling methods for the full transcriptome and specific full-length RNAs have been developed. The product portfolio encompasses library preparation kits for Illumina and Ion Torrent platforms, whole transcriptome kits, RNA isolation and cDNA amplification tools, barcoding and PCR reagents, along with software for RNA-Seq data analysis. Operations center on supporting detailed transcriptomic studies.
- Investors
Products & Services of Lexogen
Lexogen offers a comprehensive portfolio of products and services, including QuantSeq 3’ mRNA-Seq Library Prep Kits, RiboCop rRNA Depletion Kits, and SLAMseq Metabolic RNA Labeling Kit.
Tools for preparing mRNA sequencing libraries for gene expression analysis.
Kits for depleting ribosomal RNA to enhance sequencing accuracy.
Enables kinetic RNA sequencing for studying RNA dynamics.
Apps and channels of Lexogen
its YouTube channel Lexogen has 38.3K subscribers and 30 videos.
Videos from Lexogen
The most watched videos on Lexogen's YouTube channel, Lexogen (38.3K subscribers). Click a video to play it here.
More on Lexogen.
Funding Insights of Lexogen
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Lexogen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | Private Equity Round | β | FFG | β |
1 investors in total: 1 institutional.
Investors in Lexogen
Lexogen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FFG Austrian Research Promotion Agency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Management consulting and business management services are provided by FFG. | 2004 | ffg.at | Vienna, Austria |
Investor details for Lexogen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lexogen
2 dated milestones of Lexogen across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Lexogen is founded.
- Funding First funding round.
Web traffic of Lexogen
The website of Lexogen (lexogen.com) receives about 16.5K visits a month.
- Monthly visits16.5K
▼ 23.4% vs previous month
Websites whose visitors overlap most with Lexogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biology.kenyon.edu | biology.kenyon.edu | 100% | β | ||
| geneviatechnologies.com | 98% | 7.3K | #2,921,496 | View details | |
promega.de | promega.de | 97% | #537,695 | β | |
| lcsciences.com | 96% | #2,732,434 | View details | ||
| novogene.com | 96% | 366.1K | #104,051 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 20 similar websites and full traffic analytics for Lexogen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lexogen
Complete news archive for Lexogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lexogen
Lexogen was founded in 2007 and raised its 1st funding round 13 years after it was founded.
Lexogen is headquartered in Vienna, Austria.
Lexogen was founded in 2007 in Vienna, Austria, within the biotechnology sector focused on RNA research. Expression profiling methods for the full transcriptome and specific full-length RNAs have been developed. The product portfolio encompasses library preparation kits for Illumina and Ion Torrent platforms, whole transcriptome kits, RNA isolation and cDNA amplification tools, barcoding and PCR reagents, along with software for RNA-Seq data analysis. Operations center on supporting detailed transcriptomic studies.
Lexogen offers QuantSeq 3β mRNA-Seq Library Prep Kits, RiboCop rRNA Depletion Kits, and SLAMseq Metabolic RNA Labeling Kit.
Lexogen has 1 investor. Key investors include FFG Austrian Research Promotion Agency.
Lexogen operates through Lexogen Gmbh.
